Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Annales De Dermatologie Et De Venereologie
|
December 16, 2017
[On the attractiveness of a university-hospital career in medicine: Obstacles and solutions. The teachers' perspective]
M Samimi, B Dreno, S Aractingi, et al.
Cancer Immunology, Immunotherapy : CII
|
May 21, 2022
Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studies
V Moreno, E Calvo, M R Middleton, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 22, 2016
Predictors of long-term drug survival for infliximab in psoriasis
Q Magis, D Jullien, C Gaudy-Marqueste, et al.
ESMO Open
|
May 26, 2026
Concordance of pathologic response assessment between local and central review in melanoma: a post hoc analysis of KEYMAKER-U02 substudy 02C
M Tetzlaff, J M Taube, G V Long, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 23, 2021
Position statement on classification of basal cell carcinomas. Part 2: EADO proposal for new operational staging system adapted to basal cell carcinomas
J J Grob, C Gaudy-Marqueste, A Guminski, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 25, 2021
Position statement on classification of basal cell carcinomas. Part 1: unsupervised clustering of experts as a way to build an operational classification of advanced basal cell carcinoma based on pattern recognition
J J Grob, A Guminski, J Malvehy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2024
Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study
G V Long, M S Carlino, C McNeil, et al.
ESMO Open
|
May 9, 2025
Early switch from run-in with targeted to immunotherapy in advanced BRAF<sup>V600</sup>-positive melanoma: final results of the randomised phase II ImmunoCobiVem trial
E Livingstone, H J Gogas, L Kandolf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2020
ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee
O Michielin, A van Akkooi, P Lorigan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2020
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee
U Keilholz, P A Ascierto, R Dummer, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Annales De Dermatologie Et De Venereologie
|
December 16, 2017
[On the attractiveness of a university-hospital career in medicine: Obstacles and solutions. The teachers' perspective]
M Samimi, B Dreno, S Aractingi, et al.
Cancer Immunology, Immunotherapy : CII
|
May 21, 2022
Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studies
V Moreno, E Calvo, M R Middleton, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 22, 2016
Predictors of long-term drug survival for infliximab in psoriasis
Q Magis, D Jullien, C Gaudy-Marqueste, et al.
ESMO Open
|
May 26, 2026
Concordance of pathologic response assessment between local and central review in melanoma: a post hoc analysis of KEYMAKER-U02 substudy 02C
M Tetzlaff, J M Taube, G V Long, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 23, 2021
Position statement on classification of basal cell carcinomas. Part 2: EADO proposal for new operational staging system adapted to basal cell carcinomas
J J Grob, C Gaudy-Marqueste, A Guminski, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 25, 2021
Position statement on classification of basal cell carcinomas. Part 1: unsupervised clustering of experts as a way to build an operational classification of advanced basal cell carcinoma based on pattern recognition
J J Grob, A Guminski, J Malvehy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2024
Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study
G V Long, M S Carlino, C McNeil, et al.
ESMO Open
|
May 9, 2025
Early switch from run-in with targeted to immunotherapy in advanced BRAF<sup>V600</sup>-positive melanoma: final results of the randomised phase II ImmunoCobiVem trial
E Livingstone, H J Gogas, L Kandolf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2020
ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee
O Michielin, A van Akkooi, P Lorigan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2020
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee
U Keilholz, P A Ascierto, R Dummer, et al.
Page
of 5